NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 53 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $113,000 | +41.2% | 15,000 | +33.1% | 0.05% | -21.3% |
| Q1 2020 | $80,000 | +1900.0% | 11,270 | +1602.4% | 0.06% | +6000.0% |
| Q4 2019 | $4,000 | -95.3% | 662 | -96.2% | 0.00% | -96.2% |
| Q3 2019 | $86,000 | – | 17,291 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
| CM Management, LLC | 450,000 | $178,000 | 0.20% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
| AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
| Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
| Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
| PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
| Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |